Sign Up for Our Newsletter
Contact Donate

Solid Organ Transplant Immunosuppressant Therapy

Program Status


Fully Allocated – We are no longer accepting or processing applications for new or renewal patients.

Maximum Award Level

$4,500 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

Patient should be insured and insurance must cover the medication for which patient seeks assistance.
The medication must treat the disease directly.
Patient must reside and receive treatment in the United States.
Patient’s income must fall below 400% of the Federal Poverty Level.

Get Help With Your Treatment

Apply Online (Click Here) or call 1-866-316-PANF (7263)

Information About the Disease

Solid Organ Transplant Immunosuppressant (SOTI) Therapy program covers immunosuppressant therapies following a transplant of the kidney, liver, heart, lung, simultaneous heart-lung, pancreas, and simultaneous kidney-pancreas. Patient and organ survival is dependent on the use of immunosuppressant drugs. Although the combination of drugs differs from patient to patient they are always given in two phases. The first phase, called induction, carries higher doses just after the transplant surgery. The second phase is called the maintenance phase. The doses are reduced several months after the surgery to low maintenance phase levels.

For more information visit the American Transplant Foundation website or call (303) 757-0959(303) 757-0959.

For organ specific foundations visit the following:

Lung: American Lung Association or call 202 785 3355202 785 3355

Heart: American Heart Association or call 1-800-AHA-USA11-800-AHA-USA1

Pancreas: National Pancreas Foundation or call 866.726.2737866.726.2737